Home/Exuma Biotechnology/Gregory Wade, Ph.D.
GW

Gregory Wade, Ph.D.

Chief Business Officer & Head of Finance

Exuma Biotechnology

Exuma Biotechnology Pipeline

DrugIndicationPhase
Autologous HER2 Directed TMR CAR-TSolid Tumors (e.g., GI Cancers)Phase 1